614TiPUCGI 28 Panirinox: A randomized phase II study...

614TiPUCGI 28 Panirinox: A randomized phase II study assessing Panitumumab + FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis

Mazard, T, Ghiringhelli, F, Mollevi, C, Assenat, E, Gavoille, C, Smith, D, Pezzella, V, Meddeb, R, Pastor, B, Ychou, M, Thierry, A R
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy281.159
Date:
October, 2018
File:
PDF, 83 KB
2018
Conversion to is in progress
Conversion to is failed